William K Heiden - Net Worth and Insider Trading
William K Heiden Net Worth
The estimated net worth of William K Heiden is at least $7 Million dollars as of 2024-04-25. William K Heiden is the President & CEO of AMAG Pharmaceuticals Inc and owns about 490,056 shares of AMAG Pharmaceuticals Inc (AMAG) stock worth over $7 Million. William K Heiden is also the Director of Atara Biotherapeutics Inc and owns about 209,000 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $149,372. Details can be seen in William K Heiden's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William K Heiden has not made any transactions after 2023-11-10 and currently still holds the listed stock(s).
Transaction Summary of William K Heiden
William K Heiden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William K Heiden owns 3 companies in total, including Atara Biotherapeutics Inc (ATRA) , AMAG Pharmaceuticals Inc (AMAG) , and Macrogenics Inc (MGNX) .
Click here to see the complete history of William K Heiden’s form 4 insider trades.
Insider Ownership Summary of William K Heiden
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2023-11-10 | director |
| AMAG | AMAG Pharmaceuticals Inc | 2020-03-02 | director & President & CEO |
| MGNX | Macrogenics Inc | 2022-05-23 | director |
William K Heiden Latest Holdings Summary
William K Heiden currently owns a total of 2 stocks. Among these stocks, William K Heiden owns 490,056 shares of AMAG Pharmaceuticals Inc (AMAG) as of May 9, 2019, with a value of $7 Million and a weighting of 97.83%. William K Heiden also owns 209,000 shares of Atara Biotherapeutics Inc (ATRA) as of November 10, 2023, with a value of $149,372 and a weighting of 2.17%.
Latest Holdings of William K Heiden
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMAG | AMAG Pharmaceuticals Inc | 2019-05-09 | 490,056 | 13.75 | 6,738,270 |
| ATRA | Atara Biotherapeutics Inc | 2023-11-10 | 209,000 | 0.71 | 149,372 |
Holding Weightings of William K Heiden
William K Heiden Form 4 Trading Tracker
According to the SEC Form 4 filings, William K Heiden has made a total of 1 transactions in AMAG Pharmaceuticals Inc (AMAG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in AMAG Pharmaceuticals Inc is the acquisition of 10,000 shares on May 9, 2019, which cost William K Heiden around $107,000.
According to the SEC Form 4 filings, William K Heiden has made a total of 1 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Atara Biotherapeutics Inc is the acquisition of 100,000 shares on November 10, 2023, which cost William K Heiden around $25,000.
Insider Trading History of William K Heiden
- 1
William K Heiden Trading Performance
GuruFocus tracks the stock performance after each of William K Heiden's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William K Heiden is 124.71%. GuruFocus also compares William K Heiden's trading performance to market benchmark return within the same time period. The performance of stocks bought by William K Heiden within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William K Heiden's insider trading performs compared to the benchmark.
Performance of William K Heiden
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 89.19 | 124.71 | -16.18 | -17.52 | ||
| Relative Return to S&P 500(%) | 87.01 | 116.95 | -23.93 | -19.58 |
William K Heiden Ownership Network
Ownership Network List of William K Heiden
Ownership Network Relation of William K Heiden
William K Heiden Owned Company Details
What does Atara Biotherapeutics Inc do?
Who are the key executives at Atara Biotherapeutics Inc?
William K Heiden is the director of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , SVP & GC & Secretary Amar Murugan , and director & President and CEO Pascal Touchon .
Atara Biotherapeutics Inc (ATRA) Insider Trades Summary
Over the past 18 months, William K Heiden made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 151,346 shares made by Pascal Touchon , a net sale of 43,245 shares made by Amar Murugan , and a net sale of 34,741 shares made by Eric J Hyllengren .
In summary, during the past 3 months, insiders sold 56,192 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 56,192 shares. During the past 18 months, 337,881 shares of Atara Biotherapeutics Inc (ATRA) were sold and 816,825 shares were bought by its insiders, resulting in a net purchase of 478,944 shares.
Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atara Biotherapeutics Inc Insider Transactions
William K Heiden Mailing Address
Above is the net worth, insider trading, and ownership report for William K Heiden. You might contact William K Heiden via mailing address: C/o Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
